FDA OKs Selpercatinib for Adults With RET Fusion+ Solid Tumors FDA OKs Selpercatinib for Adults With RET Fusion+ Solid Tumors

The approval expands the drug label to include a variety of RET-positive tumor types, including pancreatic and colorectal cancers.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news